Panchsheel Organics Ltd (PANCHSHEEL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 867634,
    "name": "Panch.Organics",
    "stock_name": "Panch.Organics",
    "full_name": "Panchsheel Organics Ltd",
    "name_url": "stocks-analysis/panchorganics",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "121.15",
    "chg": -1.6,
    "chgp": "-1.3%",
    "dir": -1,
    "prev_price": "122.75",
    "mcapval": "162.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531726,
    "symbol": "PANCHSHEEL",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE316G01019",
    "curr_date": "Jun 03, 03:30 PM",
    "curr_time": "05:22 AM",
    "last_traded_at": "Jun 03, 03:30 PM IST",
    "bse_nse_vol": "2.82 k",
    "exc_status": "Active",
    "traded_date": "Jun 03, 2026",
    "traded_date_str": "2026 06 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/panchorganics-867634-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Panchsheel Organics Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-panchsheel-organics-ltd-latest-results-good-or-bad-4032409",
        "imagepath": "",
        "date": "2026-06-02 19:31:35",
        "description": "Panchsheel Organics Ltd's latest financial results for Q4 FY26 reveal a complex situation characterized by significant revenue growth juxtaposed with a sharp decline in profitability. The company reported net sales of ₹31.07 crores, marking a 16.24% increase quarter-on-quarter and a 9.52% rise year-on-year, which represents the highest quarterly revenue in its recent history. However, this revenue growth was overshadowed by a substantial drop in net profit, which fell to ₹1.70 crores, reflecting a 46.40% decrease from the previous quarter and a 46.37% decline year-on-year.\n\nThe operating margin, a critical indicator of profitability, contracted to 7.82%, the lowest level in eight quarters, down from 14.14% in the prior quarter and significantly below the 16.81% achieved in Q4 FY25. This margin compression raises concerns about the company's ability to manage costs effectively amidst rising operational chall..."
      },
      {
        "title": "Panchsheel Organics Q4 FY26: Margin Collapse Overshadows Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/panchsheel-organics-q4-fy26-margin-collapse-overshadows-revenue-growth-4028763",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PanchsheelOrgan_quaterlyResult_4028763.png",
        "date": "2026-06-01 15:15:02",
        "description": "Panchsheel Organics Ltd., an Indore-based active pharmaceutical ingredients (API) manufacturer, reported deeply concerning Q4 FY26 results that sent the stock tumbling 19.72% to ₹115.60 following the announcement. Whilst net sales reached a quarterly high of ₹31.07 crores—up 16.24% sequentially and 9.52% year-on-year—net profit collapsed 46.40% quarter-on-quarter to ₹1.70 crores, the lowest quarterly profit in over two years. The ₹172-crore market cap company faces mounting operational challenges despite maintaining modest top-line growth."
      },
      {
        "title": "Panchsheel Organics Ltd Reports Sharp Decline in Profitability Despite Record Quarterly Sales",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panchsheel-organics-ltd-reports-sharp-decline-in-profitability-despite-record-quarterly-sales-4026580",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PanchsheelOrgan_fintrenddot_4026580.png",
        "date": "2026-06-01 12:01:12",
        "description": "Panchsheel Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a mixed quarterly performance for the period ending March 2026. While the company achieved its highest-ever quarterly net sales at ₹31.07 crores, key profitability metrics deteriorated sharply, signalling a negative financial trend reversal from the previous quarter."
      },
      {
        "title": "Panchsheel Organics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/panchsheel-organics-ltd-is-rated-sell-4024303",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PanchsheelOrgan_mojoScore_4024303.png",
        "date": "2026-05-31 10:10:31",
        "description": "Panchsheel Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Are Panchsheel Organics Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-panchsheel-organics-ltd-latest-results-good-or-bad-4023856",
        "imagepath": "",
        "date": "2026-05-30 19:47:54",
        "description": "Panchsheel Organics Ltd's latest financial results for Q3 FY26 reflect a complex operational landscape. The company reported a net profit of ₹3.68 crore, which represents a modest year-on-year growth of 0.27%, contrasting with a significant decline of 13.85% in the same quarter last year. Revenue for the quarter stood at ₹26.73 crore, marking a year-on-year increase of 1.87%, which is a deceleration compared to the previous year's growth of 2.46%. \n\nOperating margins, however, have come under pressure, declining to 14.14% from 17.30% a year ago, indicating challenges in maintaining profitability amid rising costs or competitive pressures. Despite a sequential improvement in both net profit and revenue, the underlying trend shows that the company is grappling with margin compression, which has raised concerns about its operational efficiency.\n\nThe company's return on capital employed (ROCE) has also deterior..."
      },
      {
        "title": "When is the next results date for Panchsheel Organics Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-panchsheel-organics-ltd-4017546",
        "imagepath": "",
        "date": "2026-05-27 23:17:15",
        "description": "The next results date for Panchsheel Organics Ltd is scheduled for 30 May 2026...."
      },
      {
        "title": "Panchsheel Organics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/panchsheel-organics-ltd-is-rated-sell-4000763",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PanchsheelOrgan_mojoScore_4000763.png",
        "date": "2026-05-20 10:10:37",
        "description": "Panchsheel Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Panchsheel Organics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/panchsheel-organics-ltd-is-rated-sell-3982817",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PanchsheelOrgan_mojoScore_3982817.png",
        "date": "2026-05-09 10:10:25",
        "description": "Panchsheel Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Panchsheel Organics Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panchsheel-organics-ltd-valuation-shifts-signal-renewed-price-attractiveness-3976721",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PanchsheelOrgan_valuationdot_3976721.png",
        "date": "2026-05-06 08:00:37",
        "description": "Panchsheel Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating. This change comes amid a backdrop of mixed returns relative to the broader market and peers, prompting a reassessment of its price attractiveness based on key metrics such as P/E and P/BV ratios."
      }
    ],
    "total": 125,
    "sid": "867634",
    "stock_news_url": "https://www.marketsmojo.com/news/panchsheel-organics-867634"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "01-Jun-2026",
      "details": "Announcement under Regulation-30(LODR)- Newspaper Publication of financial results of the Panchsheel Organics Limited for the quarter and year ended 31st March 2026 approved by the board in the meeting held on 30th May 2026.",
      "source": "BSE"
    },
    {
      "caption": "Standalone And Audited Financial Results Of Panchsheel Organics Limited For The Quarter And Year Ended As On 31St March 2026",
      "datetime": "30-May-2026",
      "details": "Standalone Audited financial results of Panchsheel Organics Limited for the quarter and year ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Standalone And Audited Financial Results Of Panchsheel Organics Limited For The Quarter And Year Ended As On 31St March 2026",
      "datetime": "30-May-2026",
      "details": "Standalone Audited financial results of Panchsheel Organics Limited for the quarter and year ended 31st March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Panchsheel Organics Ltd has declared <strong>8%</strong> dividend, ex-date: 20 Feb 26",
          "dt": "2026-02-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Panchsheel Organics Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 06 Dec 21",
          "dt": "2021-12-06",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Panchsheel Organics Ltd latest results good or bad?

2026-06-02 19:31:35

Panchsheel Organics Ltd's latest financial results for Q4 FY26 reveal a complex situation characterized by significant revenue growth juxtaposed with a sharp decline in profitability. The company reported net sales of ₹31.07 crores, marking a 16.24% increase quarter-on-quarter and a 9.52% rise year-on-year, which represents the highest quarterly revenue in its recent history. However, this revenue growth was overshadowed by a substantial drop in net profit, which fell to ₹1.70 crores, reflecting a 46.40% decrease from the previous quarter and a 46.37% decline year-on-year. The operating margin, a critical indicator of profitability, contracted to 7.82%, the lowest level in eight quarters, down from 14.14% in the prior quarter and significantly below the 16.81% achieved in Q4 FY25. This margin compression raises concerns about the company's ability to manage costs effectively amidst rising operational chall...

Read full news article

Panchsheel Organics Q4 FY26: Margin Collapse Overshadows Revenue Growth

2026-06-01 15:15:02

Panchsheel Organics Ltd., an Indore-based active pharmaceutical ingredients (API) manufacturer, reported deeply concerning Q4 FY26 results that sent the stock tumbling 19.72% to ₹115.60 following the announcement. Whilst net sales reached a quarterly high of ₹31.07 crores—up 16.24% sequentially and 9.52% year-on-year—net profit collapsed 46.40% quarter-on-quarter to ₹1.70 crores, the lowest quarterly profit in over two years. The ₹172-crore market cap company faces mounting operational challenges despite maintaining modest top-line growth.

Read full news article

Panchsheel Organics Ltd Reports Sharp Decline in Profitability Despite Record Quarterly Sales

2026-06-01 12:01:12

Panchsheel Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a mixed quarterly performance for the period ending March 2026. While the company achieved its highest-ever quarterly net sales at ₹31.07 crores, key profitability metrics deteriorated sharply, signalling a negative financial trend reversal from the previous quarter.

Read full news article

Panchsheel Organics Ltd is Rated Sell

2026-05-31 10:10:31

Panchsheel Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Are Panchsheel Organics Ltd latest results good or bad?

2026-05-30 19:47:54

Panchsheel Organics Ltd's latest financial results for Q3 FY26 reflect a complex operational landscape. The company reported a net profit of ₹3.68 crore, which represents a modest year-on-year growth of 0.27%, contrasting with a significant decline of 13.85% in the same quarter last year. Revenue for the quarter stood at ₹26.73 crore, marking a year-on-year increase of 1.87%, which is a deceleration compared to the previous year's growth of 2.46%. Operating margins, however, have come under pressure, declining to 14.14% from 17.30% a year ago, indicating challenges in maintaining profitability amid rising costs or competitive pressures. Despite a sequential improvement in both net profit and revenue, the underlying trend shows that the company is grappling with margin compression, which has raised concerns about its operational efficiency. The company's return on capital employed (ROCE) has also deterior...

Read full news article

When is the next results date for Panchsheel Organics Ltd?

2026-05-27 23:17:15

The next results date for Panchsheel Organics Ltd is scheduled for 30 May 2026....

Read full news article

Panchsheel Organics Ltd is Rated Sell

2026-05-20 10:10:37

Panchsheel Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Panchsheel Organics Ltd is Rated Sell

2026-05-09 10:10:25

Panchsheel Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Panchsheel Organics Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-05-06 08:00:37

Panchsheel Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating. This change comes amid a backdrop of mixed returns relative to the broader market and peers, prompting a reassessment of its price attractiveness based on key metrics such as P/E and P/BV ratios.

Read full news article

View All News